XML 44 R34.htm IDEA: XBRL DOCUMENT
v3.26.1

FAIR VALUE (Tables) | 9 Months Ended
--- | ---
Jun. 30, 2026
Fair Value Disclosures [Abstract] |
Assets and Liabilities Measured at Fair Value on a Recurring and Nonrecurring Basis | The following tables present assets and liabilities measured at fair value on a recurring basis.
$ in millions |  | Level 1 |  | Level 2 |  | Level 3 |  | Netting adjustments (1) |  | Balance as of June 30, 2026
Assets at fair value on a recurring basis: |  |  |  |  |  |  |  |  |  |
Trading assets: |  |  |  |  |  |  |  |  |  |
Municipal and provincial obligations |  | $ | 13 |  |  | $ | 394 |  |  | $ | — |  |  | $ | — |  |  | $ | 407 |
Corporate obligations |  | 14 |  |  | 539 |  |  | — |  |  | — |  |  | 553 |
Government and agency obligations |  | 45 |  |  | 75 |  |  | — |  |  | — |  |  | 120 |
Agency mortgage-backed securities (“MBS”), collateralized mortgage obligations (“CMOs”) and asset-backed securities (“ABS”) |  | — |  |  | 379 |  |  | — |  |  | — |  |  | 379 |
Non-agency CMOs and ABS |  | — |  |  | 93 |  |  | — |  |  | — |  |  | 93 |
Total debt securities |  | 72 |  |  | 1,480 |  |  | — |  |  | — |  |  | 1,552 |
Equity securities |  | 10 |  |  | 4 |  |  | — |  |  | — |  |  | 14 |
Brokered certificates of deposit |  | — |  |  | 58 |  |  | — |  |  | — |  |  | 58 |
Other |  | — |  |  | — |  |  | 3 |  |  | — |  |  | 3 |
Total trading assets |  | 82 |  |  | 1,542 |  |  | 3 |  |  | — |  |  | 1,627 |
Available-for-sale securities (2) |  | 531 |  |  | 5,965 |  |  | — |  |  | — |  |  | 6,496 |
Derivative assets: |  |  |  |  |  |  |  |  |  |
Interest rate |  | 3 |  |  | 257 |  |  | — |  |  | (229) |  |  | 31 |
Foreign exchange |  | — |  |  | 1 |  |  | — |  |  | — |  |  | 1 |
Total derivative assets |  | 3 |  |  | 258 |  |  | — |  |  | (229) |  |  | 32 |
All other investments: |  |  |  |  |  |  |  |  |  |
Government and agency obligations (3) |  | 60 |  |  | — |  |  | — |  |  | — |  |  | 60 |
Other |  | 199 |  |  | 5 |  |  | 7 |  |  | — |  |  | 211 |
Total all other investments |  | 259 |  |  | 5 |  |  | 7 |  |  | — |  |  | 271 |
Other assets – client-owned fractional shares |  | 216 |  |  | — |  |  | — |  |  | — |  |  | 216 |
Subtotal |  | 1,091 |  |  | 7,770 |  |  | 10 |  |  | (229) |  |  | 8,642 |
Other investments – private equity – measured at net asset value (“NAV”) |  |  |  |  |  |  |  |  |  | 112 |
Total assets at fair value on a recurring basis |  | $ | 1,091 |  |  | $ | 7,770 |  |  | $ | 10 |  |  | $ | (229) |  |  | $ | 8,754 |
Liabilities at fair value on a recurring basis: |  |  |  |  |  |  |  |  |  |
Trading liabilities: |  |  |  |  |  |  |  |  |  |
Municipal and provincial obligations |  | $ | 4 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 4 |
Corporate obligations |  | — |  |  | 481 |  |  | — |  |  | — |  |  | 481 |
Government and agency obligations |  | 215 |  |  | — |  |  | — |  |  | — |  |  | 215 |
Agency MBS and CMOs |  | — |  |  | 123 |  |  | — |  |  | — |  |  | 123 |
Total debt securities |  | 219 |  |  | 604 |  |  | — |  |  | — |  |  | 823 |
Equity securities |  | 68 |  |  | — |  |  | — |  |  | — |  |  | 68 |
Total trading liabilities |  | 287 |  |  | 604 |  |  | — |  |  | — |  |  | 891 |
Derivative liabilities: |  |  |  |  |  |  |  |  |  |
Interest rate |  | 3 |  |  | 268 |  |  | — |  |  | (57) |  |  | 214 |
Foreign exchange |  | — |  |  | 1 |  |  | — |  |  | — |  |  | 1 |
Total derivative liabilities |  | 3 |  |  | 269 |  |  | — |  |  | (57) |  |  | 215 |
Other payables: |  |  |  |  |  |  |  |  |  |
Repurchase liabilities related to client-owned fractional shares |  | 216 |  |  | — |  |  | — |  |  | — |  |  | 216 |
Acquisition-related contingent consideration |  | — |  |  | — |  |  | 180 |  |  | — |  |  | 180 |
Total other payables |  | 216 |  |  | — |  |  | 180 |  |  | — |  |  | 396 |
Total liabilities at fair value on a recurring basis |  | $ | 506 |  |  | $ | 873 |  |  | $ | 180 |  |  | $ | (57) |  |  | $ | 1,502 |
$ in millions |  | Level 1 |  | Level 2 |  | Level 3 |  | Netting adjustments (1) |  | Balance as of September 30, 2025
Assets at fair value on a recurring basis: |  |  |  |  |  |  |  |  |  |
Trading assets: |  |  |  |  |  |  |  |  |  |
Municipal and provincial obligations |  | $ | 6 |  |  | $ | 403 |  |  | $ | — |  |  | $ | — |  |  | $ | 409 |
Corporate obligations |  | 11 |  |  | 659 |  |  | — |  |  | — |  |  | 670 |
Government and agency obligations |  | 41 |  |  | 108 |  |  | — |  |  | — |  |  | 149 |
Agency MBS, CMOs, and ABS |  | — |  |  | 231 |  |  | — |  |  | — |  |  | 231 |
Non-agency CMOs and ABS |  | — |  |  | 36 |  |  | — |  |  | — |  |  | 36 |
Total debt securities |  | 58 |  |  | 1,437 |  |  | — |  |  | — |  |  | 1,495 |
Equity securities |  | 17 |  |  | 3 |  |  | — |  |  | — |  |  | 20 |
Brokered certificates of deposit |  | — |  |  | 19 |  |  | — |  |  | — |  |  | 19 |
Other |  | — |  |  | — |  |  | 4 |  |  | — |  |  | 4 |
Total trading assets |  | 75 |  |  | 1,459 |  |  | 4 |  |  | — |  |  | 1,538 |
Available-for-sale securities (2) |  | 430 |  |  | 6,458 |  |  | — |  |  | — |  |  | 6,888 |
Derivative assets: |  |  |  |  |  |  |  |  |  |
Interest rate |  | 2 |  |  | 304 |  |  | — |  |  | (239) |  |  | 67 |
Foreign exchange |  | — |  |  | 1 |  |  | — |  |  | — |  |  | 1 |
Total derivative assets |  | 2 |  |  | 305 |  |  | — |  |  | (239) |  |  | 68 |
All other investments: |  |  |  |  |  |  |  |  |  |
Government and agency obligations (3) |  | 92 |  |  | — |  |  | — |  |  | — |  |  | 92 |
Other |  | 185 |  |  | 1 |  |  | 7 |  |  | — |  |  | 193 |
Total all other investments |  | 277 |  |  | 1 |  |  | 7 |  |  | — |  |  | 285 |
Other assets – client-owned fractional shares |  | 171 |  |  | — |  |  | — |  |  | — |  |  | 171 |
Subtotal |  | 955 |  |  | 8,223 |  |  | 11 |  |  | (239) |  |  | 8,950 |
Other investments – private equity – measured at NAV |  |  |  |  |  |  |  |  |  | 105 |
Total assets at fair value on a recurring basis |  | $ | 955 |  |  | $ | 8,223 |  |  | $ | 11 |  |  | $ | (239) |  |  | $ | 9,055 |
Liabilities at fair value on a recurring basis: |  |  |  |  |  |  |  |  |  |
Trading liabilities: |  |  |  |  |  |  |  |  |  |
Municipal and provincial obligations |  | $ | 3 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 3 |
Corporate obligations |  | — |  |  | 651 |  |  | — |  |  | — |  |  | 651 |
Government and agency obligations |  | 164 |  |  | — |  |  | — |  |  | — |  |  | 164 |
Agency MBS and CMOs |  | — |  |  | 42 |  |  | — |  |  | — |  |  | 42 |
Total debt securities |  | 167 |  |  | 693 |  |  | — |  |  | — |  |  | 860 |
Equity securities |  | 31 |  |  | — |  |  | — |  |  | — |  |  | 31 |
Total trading liabilities |  | 198 |  |  | 693 |  |  | — |  |  | — |  |  | 891 |
Derivative liabilities: |  |  |  |  |  |  |  |  |  |
Interest rate |  | 3 |  |  | 306 |  |  | — |  |  | (123) |  |  | 186 |
Foreign exchange |  | — |  |  | 2 |  |  | — |  |  | — |  |  | 2 |
Other |  | — |  |  | — |  |  | 2 |  |  | — |  |  | 2 |
Total derivative liabilities |  | 3 |  |  | 308 |  |  | 2 |  |  | (123) |  |  | 190 |
Other payables – repurchase liabilities related to client-owned fractional shares |  | 171 |  |  | — |  |  | — |  |  | — |  |  | 171 |
Total liabilities at fair value on a recurring basis |  | $ | 372 |  |  | $ | 1,001 |  |  | $ | 2 |  |  | $ | (123) |  |  | $ | 1,252 |
(1)Netting adjustments represent the impact of counterparty and collateral netting on our derivative balances included on our Condensed Consolidated Statements of Financial Condition. See Note 6 for additional information. (2)Our available-for-sale securities primarily consist of agency MBS, agency CMOs, and U.S. Treasury securities (“U.S. Treasuries”). See Note 5 for further information. (3)These assets are primarily comprised of U.S. Treasuries purchased to meet certain deposit requirements with clearing organizations.
Level 3 Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis, Roll Forward Table of Change in Balances | The following tables present the changes in fair value for Level 3 financial assets and financial liabilities measured at fair value on a recurring basis. The realized and unrealized gains and losses in the tables may include changes in fair value that were attributable to both observable and unobservable inputs. In the following tables, gains/(losses) on trading and derivative instruments are reported in “Principal transactions,” gains/(losses) on other investments are reported in “Other” revenues, and gains/(losses) on acquisition-related contingent consideration are reported in “Other” expense on our Condensed Consolidated Statements of Income and Comprehensive Income.
Three months ended June 30, 2026 Level 3 instruments at fair value
|  | Financial assets |  |  | Financial liabilities
|  | Trading assets |  |  |  |  |  |  |  | All other investments |  |  | Trading liabilities |  |  |  |  |  | Acquisition-related contingent consideration
$ in millions |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair value beginning of period |  | $ | 2 |  |  |  |  |  |  |  |  | $ | 7 |  |  |  | $ | (1) |  |  |  |  |  |  | $ | (28) |
Total gains/(losses) included in earnings |  | — |  |  |  |  |  |  |  |  | — |  |  |  | 1 |  |  |  |  |  |  | (3) |
Purchases and contributions |  | 9 |  |  |  |  |  |  |  |  | — |  |  |  | — |  |  |  |  |  |  | (149) |
Sales and distributions |  | (8) |  |  |  |  |  |  |  |  | — |  |  |  | — |  |  |  |  |  |  | — |
Transfers: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Into Level 3 |  | — |  |  |  |  |  |  |  |  | — |  |  |  | — |  |  |  |  |  |  | — |
Out of Level 3 |  | — |  |  |  |  |  |  |  |  | — |  |  |  | — |  |  |  |  |  |  | — |
Fair value end of period |  | $ | 3 |  |  |  |  |  |  |  |  | $ | 7 |  |  |  | $ | — |  |  |  |  |  |  | $ | (180) |
Unrealized gains/(losses) for the period included in earnings for instruments held at the end of the reporting period |  | $ | — |  |  |  |  |  |  |  |  | $ | — |  |  |  | $ | — |  |  |  |  |  |  | $ | (3) |
Nine months ended June 30, 2026 Level 3 instruments at fair value
|  | Financial assets |  |  |  |  |  | Financial liabilities
|  | Trading assets |  |  |  |  |  | All other investments |  |  |  |  |  | Derivative liabilities |  |  | Acquisition-related contingent consideration
$ in millions |  |  |  |  |  |  |  |  |  |  |  |  |
Fair value beginning of period |  | $ | 4 |  |  |  |  |  |  | $ | 7 |  |  |  |  |  |  | $ | (2) |  |  |  | $ | — |
Total gains/(losses) included in earnings |  | 1 |  |  |  |  |  |  | — |  |  |  |  |  |  | 1 |  |  |  | (3) |
Purchases and contributions |  | 59 |  |  |  |  |  |  | — |  |  |  |  |  |  | — |  |  |  | (177) |
Sales and distributions |  | (61) |  |  |  |  |  |  | — |  |  |  |  |  |  | 1 |  |  |  | — |
Transfers: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Into Level 3 |  | — |  |  |  |  |  |  | — |  |  |  |  |  |  | — |  |  |  | — |
Out of Level 3 |  | — |  |  |  |  |  |  | — |  |  |  |  |  |  | — |  |  |  | — |
Fair value end of period |  | $ | 3 |  |  |  |  |  |  | $ | 7 |  |  |  |  |  |  | $ | — |  |  |  | $ | (180) |
Unrealized gains/(losses) for the period included in earnings for instruments held at the end of the reporting period |  | $ | — |  |  |  |  |  |  | $ | — |  |  |  |  |  |  | $ | — |  |  |  | $ | (3) |
Three months ended June 30, 2025 Level 3 instruments at fair value
|  | Financial assets |  |  |  |  |  |  |  |  |
$ in millions |  | Trading assets |  |  | Derivative assets |  |  |  |  | All other investments |  |  |  |  |  |  |  |  |
Fair value beginning of period |  | $ | 1 |  |  |  | $ | 6 |  |  |  |  |  | $ | 7 |  |  |  |  |  |  |  |  |  |
Total gains/(losses) included in earnings |  | 1 |  |  |  | (5) |  |  |  |  |  | — |  |  |  |  |  |  |  |  |  |
Purchases and contributions |  | 27 |  |  |  | — |  |  |  |  |  | — |  |  |  |  |  |  |  |  |  |
Sales and distributions |  | (27) |  |  |  | — |  |  |  |  |  | — |  |  |  |  |  |  |  |  |  |
Transfers: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Into Level 3 |  | — |  |  |  | — |  |  |  |  |  | — |  |  |  |  |  |  |  |  |  |
Out of Level 3 |  | — |  |  |  | — |  |  |  |  |  | — |  |  |  |  |  |  |  |  |  |
Fair value end of period |  | $ | 2 |  |  |  | $ | 1 |  |  |  |  |  | $ | 7 |  |  |  |  |  |  |  |  |  |
Unrealized gains/(losses) for the period included in earnings for instruments held at the end of the reporting period |  | $ | — |  |  |  | $ | (5) |  |  |  |  |  | $ | — |  |  |  |  |  |  |  |  |  |
Nine months ended June 30, 2025 Level 3 instruments at fair value
|  | Financial assets |  |  |  |  |  |  |  |  |
$ in millions |  | Trading assets |  |  |  | Derivative assets |  |  |  |  |  | All other investments |  |  |  |  |  |  |  |  |
Fair value beginning of period |  | $ | 3 |  |  |  |  | $ | 4 |  |  |  |  |  |  | $ | 7 |  |  |  |  |  |  |  |  |  |
Total gains/(losses) included in earnings |  | 2 |  |  |  |  | (3) |  |  |  |  |  |  | — |  |  |  |  |  |  |  |  |  |
Purchases and contributions |  | 66 |  |  |  |  | — |  |  |  |  |  |  | — |  |  |  |  |  |  |  |  |  |
Sales and distributions |  | (69) |  |  |  |  | — |  |  |  |  |  |  | — |  |  |  |  |  |  |  |  |  |
Transfers: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Into Level 3 |  | — |  |  |  |  | — |  |  |  |  |  |  | — |  |  |  |  |  |  |  |  |  |
Out of Level 3 |  | — |  |  |  |  | — |  |  |  |  |  |  | — |  |  |  |  |  |  |  |  |  |
Fair value end of period |  | $ | 2 |  |  |  |  | $ | 1 |  |  |  |  |  |  | $ | 7 |  |  |  |  |  |  |  |  |  |
Unrealized gains/(losses) for the period included in earnings for instruments held at the end of the reporting period |  | $ | — |  |  |  |  | $ | (2) |  |  |  |  |  |  | $ | — |  |  |  |  |  |  |  |  |  |
Net Asset Value of Recorded Value and Unfunded Commitments | The following table presents the recorded value and unfunded commitments related to our private equity investments portfolio.
$ in millions |  | Recorded value |  | Unfunded commitment
June 30, 2026 |  |  |  |
Private equity investments measured at NAV |  | $ | 112 |  |  | $ | 34 |
Private equity investments not measured at NAV |  | 7 |  |  |
Total private equity investments |  | $ | 119 |  |  |
September 30, 2025 |  |  |  |
Private equity investments measured at NAV |  | $ | 105 |  |  | $ | 38 |
Private equity investments not measured at NAV |  | 7 |  |  |
Total private equity investments |  | $ | 112 |  |  |
Fair Value Measurements, Nonrecurring | The following table presents assets measured at fair value on a nonrecurring basis along with the valuation techniques and significant unobservable inputs used in the valuation of the assets classified as Level 3. These inputs represent those that a market participant would take into account when pricing these instruments. Weighted averages are calculated by weighting each input by the relative fair value of the related financial instrument.
$ in millions |  |  |  | Level 2 |  | Level 3 |  | Total fair value |  | Valuation technique(s) |  | Unobservable input |  | Range (weighted-average)
June 30, 2026 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Bank loans: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Residential mortgage loans |  |  |  | $ | 1 |  |  | $ | 7 |  |  | $ | 8 |  |  | Collateral or discounted cash flow (1) |  | Prepayment rate |  | 7 yrs. - 12 yrs. (10.6 yrs.)
Corporate loans |  |  |  | $ | — |  |  | $ | 133 |  |  | $ | 133 |  |  | Collateral or discounted cash flow (1) |  | Recovery rate |  | 38% - 87% (70%)
Loans held for sale |  |  |  | $ | 38 |  |  | $ | — |  |  | $ | 38 |  |  | N/A (2) |  | N/A |  | N/A
September 30, 2025 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Bank loans: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Residential mortgage loans |  |  |  | $ | 5 |  |  | $ | 7 |  |  | $ | 12 |  |  | Collateral or discounted cash flow (1) |  | Prepayment rate |  | 7 yrs. - 12 yrs. (10.5 yrs.)
Corporate loans |  |  |  | $ | — |  |  | $ | 179 |  |  | $ | 179 |  |  | Collateral or discounted cash flow (1) |  | Recovery rate |  | 24% - 96% (76%)
Loans held for sale |  |  |  | $ | 31 |  |  | $ | — |  |  | $ | 31 |  |  | N/A (2) |  | N/A |  | N/A
(1)The valuation techniques used to estimate the fair values are based on collateral value less selling costs for the collateral-dependent loans and discounted cash flows for loans that are not collateral-dependent. Unobservable inputs used in the collateral valuation technique are not meaningful and unobservable inputs used in the discounted cash flow valuation technique are presented in the preceding table. (2)See the “Bank loans, net - Loans held for sale” section of Note 2 of our 2025 Form 10-K for information on the valuation techniques used in the valuation of our loans held for sale measured at fair value on a nonrecurring basis.
Carrying Amounts and Estimated Fair Values of Financial Instruments Not Carried at Fair Value | The following table presents the estimated fair value and fair value hierarchy of financial assets and liabilities that are not recorded at fair value on the Condensed Consolidated Statements of Financial Condition at June 30, 2026 and September 30, 2025. This table excludes financial instruments that are carried at amounts which approximate fair value. See Note 3 of our 2025 Form 10-K for a discussion of our financial instruments that are not recorded at fair value.
$ in millions |  |  |  | Level 2 |  | Level 3 |  | Total estimated fair value |  | Carrying amount
June 30, 2026 |  |  |  |  |  |  |  |  |  |
Financial assets: |  |  |  |  |  |  |  |  |  |
Bank loans, net |  |  |  | $ | 96 |  |  | $ | 55,529 |  |  | $ | 55,625 |  |  | $ | 56,048 |
Financial liabilities: |  |  |  |  |  |  |  |  |  |
Bank deposits - certificates of deposit |  |  |  | $ | 3,312 |  |  | $ | — |  |  | $ | 3,312 |  |  | $ | 3,326 |
Senior notes payable |  |  |  | $ | 3,216 |  |  | $ | — |  |  | $ | 3,216 |  |  | $ | 3,522 |
September 30, 2025 |  |  |  |  |  |  |  |  |  |
Financial assets: |  |  |  |  |  |  |  |  |  |
Bank loans, net |  |  |  | $ | 386 |  |  | $ | 50,362 |  |  | $ | 50,748 |  |  | $ | 51,345 |
Financial liabilities: |  |  |  |  |  |  |  |  |  |
Bank deposits - certificates of deposit |  |  |  | $ | 1,943 |  |  | $ | — |  |  | $ | 1,943 |  |  | $ | 1,937 |
Senior notes payable |  |  |  | $ | 3,299 |  |  | $ | — |  |  | $ | 3,299 |  |  | $ | 3,520 |

X
- Definition Tabular disclosure of the fair value measurement of assets and liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period. + References No definition available. + Details
Name: | rjf_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock
Namespace Prefix: | rjf_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of financial instrument measured at fair value on recurring or nonrecurring basis. Includes, but is not limited to, instrument classified in shareholders' equity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 100 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3 + Details
Name: | us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets and liabilities by class, including financial instruments measured at fair value that are classified in shareholders' equity, if any, that are measured at fair value on a nonrecurring basis in periods after initial recognition (for example, impaired assets). Disclosures may include, but are not limited to: (a) the fair value measurements recorded and the reasons for the measurements and (b) the level within the fair value hierarchy in which the fair value measurements are categorized in their entirety (levels 1, 2, 3). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482881/825-10-55-10 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482881/825-10-55-12 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-13 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-12 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11 + Details
Name: | us-gaap_FairValueByBalanceSheetGroupingTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of investments in certain entities that calculate net asset value per share or equivalent measured at fair value on a recurring or nonrecurring basis. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 107 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 35 -Paragraph 54B -Publisher FASB -URI https://asc.fasb.org/1943274/2147482134/820-10-35-54B Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-8 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A + Details
Name: | us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration